Additional $12M financing led by Elevage Medical Technologies and Jonathan Milner alongside existing investors British ...

Global Bioprocess Containers Market OverviewThe global bioprocess containers market is projected to register robust growth, expanding at a CAGR of approximately 28% through 2029. This strong growth ...

Nuclera has expanded its Series C funding round to USD $87 million following a new USD $12 million extension led by Elevage ...

Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains the critical challenges of developing bispecific ...

The funding will support further development of eProtein Discovery to enable full-format antibody expression, purification, ...

Cambridge biotech Nuclera has boosted its Series C round to $87 million after securing a further $12m from a range of backers ...

Nuclera has announced a $12million extension to its Series C round which raised $75m in October 2024. The raise was led by ...

A biotech which seeks to accelerate drug discovery by providing easy access to functional proteins through its proprietary platform has extended its total Series C funding to £64.5m.

Laine Mello, director of marketing at Ecolab Bioprocessing, reflects on how the use of digital technologies expanded in the pharma industry in 2025 and how new complex molecules will continue to drive ...

A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor ...

GlobalData analyst Vasilis Roumpelakis notes that bispecifics could hold strong potential in the future, but manufacturing and payer acceptance challenges remain.

This study presents a comprehensive approach for assessing multiple quality attributes of antibody-oligonucleotide conjugates ...